Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Integrated with the company’s industry-leading site payment technology, the new solution delivers efficiency and accuracy to support a streamlined and optimized study start-up

KING OF PRUSSIA, Pa. – June 2, 2020 – Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up. The new budget development solution streamlines trial initiation for sponsors and CROs and eliminates guesswork during the budgeting process to deliver a smarter, more efficient workflow.

EnvisiX seamlessly integrates with eClinicalGPS, Greenphire’s industry-leading site payment solution, enabling unprecedented simplicity and efficiency throughout a trial from budget creation and negotiation to management, execution, and tracking of global investigator grants.

Read more.